Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Bilbao Vizcaya Argentaria SA vs Summit Therapeutics Inc — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $28.6 (market cap $157.51B), while Summit Therapeutics Inc trades at $15.34 (market cap $12.06B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 13.1× Summit Therapeutics Inc's market cap, and Banco Bilbao Vizcaya Argentaria SA pays a 3.8% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BBVA | SMMT | |
|---|---|---|
Market Cap | $157.51B | $12.06B |
Sector | Financials | Health |
52-Week High | $28.50 | $26.98 |
52-Week Low | $17.96 | $12.55 |
Dividend Yield | 3.8% | — |
Enterprise Value | — | $11.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
